185 related articles for article (PubMed ID: 12801736)
21. Fatal injury in eastern Sri Lanka, with special reference to cardenolide self-poisoning with Cerbera manghas fruits.
Eddleston M; Haggalla S
Clin Toxicol (Phila); 2008 Sep; 46(8):745-8. PubMed ID: 18803087
[TBL] [Abstract][Full Text] [Related]
22. Diurnal variation in probability of death following self-poisoning in Sri Lanka--evidence for chronotoxicity in humans.
Carroll R; Metcalfe C; Gunnell D; Mohamed F; Eddleston M
Int J Epidemiol; 2012 Dec; 41(6):1821-8. PubMed ID: 23179303
[TBL] [Abstract][Full Text] [Related]
23. Physical vulnerability and fatal self-harm in the elderly.
Eddleston M; Dissanayake M; Sheriff MH; Warrell DA; Gunnell D
Br J Psychiatry; 2006 Sep; 189():278-9. PubMed ID: 16946365
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of activated charcoal in yellow oleander poisoning.
Peiris-John RJ; Wickremasinghe AR
Ceylon Med J; 2008 Jun; 53(2):33-5. PubMed ID: 18678118
[No Abstract] [Full Text] [Related]
25. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
J Toxicol Clin Toxicol; 1999; 37(6):731-51. PubMed ID: 10584586
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature.
Camphausen C; Haas NA; Mattke AC
Z Kardiol; 2005 Dec; 94(12):817-23. PubMed ID: 16382383
[TBL] [Abstract][Full Text] [Related]
27. The comparative efficacy of various multiple-dose activated charcoal regimens.
Ilkhanipour K; Yealy DM; Krenzelok EP
Am J Emerg Med; 1992 Jul; 10(4):298-300. PubMed ID: 1616516
[TBL] [Abstract][Full Text] [Related]
28. Researching nature's venoms and poisons.
Warrell DA
Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):860-6. PubMed ID: 19328509
[TBL] [Abstract][Full Text] [Related]
29. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
Brahmi N; Kouraichi N; Thabet H; Amamou M
Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
[TBL] [Abstract][Full Text] [Related]
30. Applied clinical pharmacology and public health in rural Asia--preventing deaths from organophosphorus pesticide and yellow oleander poisoning.
Eddleston M
Br J Clin Pharmacol; 2013 May; 75(5):1175-88. PubMed ID: 22943579
[TBL] [Abstract][Full Text] [Related]
31. Deaths due to absence of an affordable antitoxin for plant poisoning.
Eddleston M; Senarathna L; Mohamed F; Buckley N; Juszczak E; Sheriff MH; Ariaratnam A; Rajapakse S; Warrell D; Rajakanthan K
Lancet; 2003 Sep; 362(9389):1041-4. PubMed ID: 14522536
[TBL] [Abstract][Full Text] [Related]
32. Multiple-dose activated charcoal: a review of relevant clinical studies.
Bradberry SM; Vale JA
J Toxicol Clin Toxicol; 1995; 33(5):407-16. PubMed ID: 7650765
[TBL] [Abstract][Full Text] [Related]
33. A study of socio clinical, biochemical and electrocardiographic changes of yellow oleander seed poisoning in India.
Subramani M; Anbarasan M; Deepalatha S; Muthumani LN; Mahesh MA
Bioinformation; 2023; 19(3):244-250. PubMed ID: 37808385
[TBL] [Abstract][Full Text] [Related]
34. Role of repeated doses of oral activated charcoal in the treatment of acute intoxications.
McLuckie A; Forbes AM; Ilett KF
Anaesth Intensive Care; 1990 Aug; 18(3):375-84. PubMed ID: 2221332
[TBL] [Abstract][Full Text] [Related]
35. Management of acute yellow oleander poisoning.
Eddleston M; Warrell DA
QJM; 1999 Sep; 92(9):483-5. PubMed ID: 10627866
[No Abstract] [Full Text] [Related]
36. Acute oleander poisoning: A study of clinical profile from a tertiary care center in South India.
Karthik G; Iyadurai R; Ralph R; Prakash V; Abhilash KPP; Sathyendra S; Abraham OC; Truman C; Reginald A
J Family Med Prim Care; 2020 Jan; 9(1):136-140. PubMed ID: 32110579
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological treatment of cardiac glycoside poisoning.
Roberts DM; Gallapatthy G; Dunuwille A; Chan BS
Br J Clin Pharmacol; 2016 Mar; 81(3):488-95. PubMed ID: 26505271
[TBL] [Abstract][Full Text] [Related]
38. The frequency of complications associated with the use of multiple-dose activated charcoal.
Dorrington CL; Johnson DW; Brant R;
Ann Emerg Med; 2003 Mar; 41(3):370-7. PubMed ID: 12605204
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular effects of yellow oleander ingestion.
Bose TK; Basu RK; Biswas B; De JN; Majumdar BC; Datta S
J Indian Med Assoc; 1999 Oct; 97(10):407-10. PubMed ID: 10638101
[TBL] [Abstract][Full Text] [Related]
40. Activated charcoal is effective but equilibrium dialysis is ineffective in removing oleander leaf extract and oleandrin from human serum: monitoring the effect by measuring apparent digoxin concentration.
Dasgupta A; Cao S; Wells A
Ther Drug Monit; 2003 Jun; 25(3):323-30. PubMed ID: 12766561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
